Growth of bacteriophage f2 in E. coli treated with rifampicin.
- 1 September 1968
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 61 (1) , 184-191
- https://doi.org/10.1073/pnas.61.1.184
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Virus-specific proteins in Escherichia coli infected with some amber mutants of phage MS2Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1968
- The specific inhibition of the DNA-directed RNA synthesis by rifamycinBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1967
- Amber mutants and chain termination in vitroJournal of Molecular Biology, 1967
- Differential synthesis of bacteriophage-specific proteins in MS2-infected Escherichia coli treated with actinomycinJournal of Molecular Biology, 1966
- BACTERIOPHAGE-SPECIFIC PROTEINS IN E. COLI INFECTED WITH AN RNA BACTERIOPHAGEProceedings of the National Academy of Sciences, 1966
- Replication of the RNA of Bacteriophage f2Science, 1966
- Rifampicin: A New Orally Active RifamycinChemotherapy, 1966
- The replication of bacteriophage MS2Journal of Molecular Biology, 1965
- DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS*Annals of the New York Academy of Sciences, 1964
- Host-dependent mutants of the bacteriophage f2 IV. On the Biosynthesis of a viral RNA polymeraseVirology, 1964